Financial Performance - Net sales for the year ended December 31, 2024, were 128,133,adecreaseof11,199 or 8.0% compared to 139,332in2023[106]−GrossprofitfortheyearendedDecember31,2024,was16,722, down 6,382or27.623,104 in 2023, resulting in a gross margin percentage of 13.1%[111] - Operating loss for the year ended December 31, 2024, was (195),comparedtooperatingincomeof5,953 in 2023, representing a decrease of 103.3%[115] - Net loss for 2024 was 1,295,or0.47 per diluted share, compared to net income of 6,874,or2.38 per diluted share in 2023[118] Order Backlog and Shipments - The total order backlog as of December 31, 2024, was 65,852,reflectinga28.226,451, down 24.8% from December 31, 2023[107] Expenses and Charges - Selling expenses decreased by 152,or4.2571 related to the closure of the Blue Earth facility[114] Cash Flow and Financing - Cash used in operating activities for the year ended December 31, 2024 was 2,250,comparedtocashprovidedbyoperationsof1,769 for 2023, indicating a significant decrease in operational cash flow[125] - Net cash provided by financing activities in 2024 was 2,765,mainlyfromnetproceedsof2,849 from the line of credit and 345fromnotespayable,contrastingwithcashusedof1,281 in 2023[127] - The company replaced its asset-backed line of credit with a 15,000SeniorSecuredRevolvingLineofCreditonFebruary29,2024[120]−ThefinancingagreementwithChinaConstructionBankprovidesalineofcreditof10,000,000RMB(approximately1.4millionUSD)expiringonSeptember9,2025,withaninterestrateofapproximately413,792 for unbilled customer net sales included in net sales[132] - The company had an inventory reserve of 1,446asofDecember31,2024,reflectingongoingevaluationsofslow−movingandexcessinventory[135]TaxPositions−Thereserveforuncertaintaxpositionswas97 as of December 31, 2024, indicating potential challenges in tax positions taken by the company[137] - A tax benefit of $2,600 was recorded in 2023 due to the reversal of a previously established valuation allowance against net U.S. deferred tax assets[136] - The company anticipates future adjustments to the deferred tax asset valuation allowance based on changes in expected realizations, which could materially affect financial results[136] Impairment and Valuation - The company has no long-lived asset impairment as of December 31, 2024, despite its common stock trading below net equity value[133]